Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical Review

Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients

(2011) Po-Hsiu Kuo et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications

(2011) T A P Lett et al.   MOLECULAR PSYCHIATRY

Functional consequences of twoHTR2Cpolymorphisms associated with antipsychotic-induced weight gain

(2011) Matthew J Hill et al.   PHARMACOGENOMICS

Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication

(2011) Jelle Vehof et al.   PSYCHOPHARMACOLOGY

Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients

(2010) Arun K. Tiwari et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Effect of FTO, SH2B1, LEP, and LEPR Polymorphisms on Weight Gain Associated With Antipsychotic Treatment

(2010) Rocio Perez-Iglesias et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Association Between the 1291-C/G Polymorphism in the Adrenergic α-2a Receptor and the Metabolic Syndrome

(2010) Arne J. Risselada et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Endocannabinoid Pro129Thr FAAH Functional Polymorphism But Not 1359G/A CNR1 Polymorphism Is Associated With Antipsychotic-Induced Weight Gain

(2010) Palmiero Monteleone et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

(2010) D E Adkins et al.   MOLECULAR PSYCHIATRY

A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia

(2010) Arun K Tiwari et al.   NEUROPSYCHOPHARMACOLOGY

DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia

(2010) Todd Lencz et al.   Pharmacogenetics and Genomics

Polymorphisms of theHTR2Cgene and antipsychotic-induced weight gain: an update and meta-analysis

(2010) Michelle N Sicard et al.   PHARMACOGENOMICS

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

(2010) A J Risselada et al.   PHARMACOGENOMICS JOURNAL

Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study

(2009) S. Gebhardt et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Multiple Genetic Factors in Olanzapine-Induced Weight Gain in Schizophrenia Patients

(2009) Hiroshi Ujike et al.   JOURNAL OF CLINICAL PSYCHIATRY

Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms

(2009) Gavin P Reynolds et al.   PHARMACOLOGY & THERAPEUTICS

Weight effects associated with antipsychotics: A comprehensive database analysis

(2009) Bruce Parsons et al.   SCHIZOPHRENIA RESEARCH

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

(2008) Olga O. Yevtushenko et al.   BRITISH JOURNAL OF PSYCHIATRY

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

(2008) S Le Hellard et al.   MOLECULAR PSYCHIATRY

Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels

(2007) Jose de Leon et al.   SCHIZOPHRENIA RESEARCH